Department of Reproductive Medicine, The First People's Hospital of Yunnan Province, Kunming, China.
Reproductive Medical Center of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.
Front Endocrinol (Lausanne). 2022 Feb 21;13:830567. doi: 10.3389/fendo.2022.830567. eCollection 2022.
To assess the impact of serum luteinizing hormone (LH) levels on the day of initiation of controlled ovarian stimulation (COS) after pituitary suppression on early pregnancy loss and assisted reproductive technology (ART) outcomes.
Retrospective cohort study.
University-affiliated hospital.
A total of 9540 normogonadotrophic patients were treated with a GnRH agonist for fertilization (IVF). Based on the serum concentration of LH on the COS initiation day, patients were divided into low (<1 mIU/mL, n=2838), medium (1-1.49 mIU/mL, n=3357), or high (≥1.5 mIU/mL, n=3345) LH groups and received either fresh embryo transfer (ET) or frozen ET (women with high ovarian response, insufficient endometrial thickness, or requesting frozen ET). A total of 6279 cycles were fresh ET (1960, 2222, and 2097 in the low, medium, and high LH groups, respectively).
During IVF/ICSI, a GnRH agonist was used to suppress pituitary function in the midluteal phase or follicular phase, and then gonadotropin was used to induce COS.
The early pregnancy loss rate (ePLR) and live-birth rate (LBR) for fresh ET, as well as the cumulative ePLR and LBR for the entire ovarian stimulation cycle, were compared.
In the fresh ET cycles, the high, medium and low LH groups had an ePLR of 8.6%, 11.9% and 12.5%, respectively, and LBR of 42.1%, 37.9% and 37.5%, respectively. There were no significant differences in terms of clinical pregnancy rate (CPR), late pregnancy loss rate (lPLR), and ectopic pregnancy rate (EPR) among the three LH groups. For the entire ovarian stimulation cycle, the high LH group had a greater number of retrieved oocytes compared with the low and medium LH groups. Among the groups of high, medium and low LH, the cumulative CPR were 72.8%, 69.8% and 68.8%, respectively, and the cumulative LBR were 63.4%, 60.4% and 58.5%, respectively. There were no significant differences in the cumulative ePLR, lPLR, or EPR. After multivariable logistic regression, compared with the high LH group, the adjusted odds ratio of early pregnancy loss in the low and medium LH group were 1.429 (1.065-1.919, = 0.018) and 1.389 (1.041-1.853, = 0.026).
After pituitary suppression by a GnRH-agonist during IVF, a low LH level (<1.5 mIU/mL) on the COS initiation day was associated with adverse ART outcomes-including fewer oocytes, higher ePLR and lower LBR in fresh ET-and lower cumulative CPR and LBR in the entire ovarian-stimulation cycle. And LH on the COS initiation day was an independent factor affecting ePLR after multivariate regression.
评估垂体抑制后控制性卵巢刺激(COS)启动日血清黄体生成素(LH)水平对早期妊娠丢失和辅助生殖技术(ART)结局的影响。
回顾性队列研究。
大学附属医院。
共 9540 例正常促性腺激素患者接受 GnRH 激动剂进行受精(IVF)。根据 COS 启动日血清 LH 浓度,患者分为低(<1 mIU/mL,n=2838)、中(1-1.49 mIU/mL,n=3357)或高(≥1.5 mIU/mL,n=3345)LH 组,并接受新鲜胚胎移植(ET)或冷冻 ET(卵巢反应高、子宫内膜厚度不足或要求冷冻 ET 的妇女)。共进行了 6279 个新鲜 ET 周期(低、中、高 LH 组分别为 1960、2222 和 2097 个周期)。
在 IVF/ICSI 期间,使用 GnRH 激动剂在黄体中期或卵泡期抑制垂体功能,然后使用促性腺激素诱导 COS。
新鲜 ET 的早期妊娠丢失率(ePLR)和活产率(LBR),以及整个卵巢刺激周期的累积 ePLR 和 LBR。
在新鲜 ET 周期中,高、中、低 LH 组的 ePLR 分别为 8.6%、11.9%和 12.5%,LBR 分别为 42.1%、37.9%和 37.5%。三组间临床妊娠率(CPR)、晚期妊娠丢失率(lPLR)和异位妊娠率(EPR)无显著差异。对于整个卵巢刺激周期,高 LH 组的获卵数多于低和中 LH 组。在高、中、低 LH 组中,累积 CPR 分别为 72.8%、69.8%和 68.8%,累积 LBR 分别为 63.4%、60.4%和 58.5%。累积 ePLR、lPLR 和 EPR 无显著差异。多变量逻辑回归后,与高 LH 组相比,低和中 LH 组的早期妊娠丢失调整比值比分别为 1.429(1.065-1.919,=0.018)和 1.389(1.041-1.853,=0.026)。
在 IVF 中使用 GnRH-激动剂抑制垂体后,COS 启动日 LH 水平较低(<1.5 mIU/mL)与不良的 ART 结局相关,包括新鲜 ET 中获卵数减少、ePLR 升高和 LBR 降低,以及整个卵巢刺激周期中累积 CPR 和 LBR 降低。并且 LH 是多变量回归后影响 ePLR 的独立因素。